EXPOSURE RESPONSE ANALYSIS AS EVIDENCE FOR APPROVAL OF CANAGLIFLOZIN-METFORMIN IMMEDIATE RELEASE FIXED-DOSE COMBINATION PRODUCT: A REGULATORY PERSPECTIVE.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2015）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined